← Back to Search

Nonsteroidal Anti-inflammatory Drug

Ketorolac 30mg oral for Female Infertility

Phase 4
Waitlist Available
Led By Bruce Pier
Research Sponsored by Madigan Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes after procedure
Awards & highlights

Study Summary

This trial looks at whether ketorolac or ibuprofen is better at reducing pain during HSG testing, a vital but painful part of infertility treatment.

Eligible Conditions
  • Female Infertility

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes after procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes after procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain during contrast infiltration
Secondary outcome measures
Pain 5 minutes following HSG
Pain at baseline (before procedure start)
Pain at completion of HSG
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: KetorolacExperimental Treatment1 Intervention
Patients randomized to this arm will receive an identical capsule to the other patient arm, and receive 30mg ketorolac 1 hour before HSG.
Group II: IbuprofenExperimental Treatment1 Intervention
Patients randomized to this arm will receive an identical capsule to the other patient arm, and receive 800mg ibuprofen 1 hour before HSG.

Find a Location

Who is running the clinical trial?

Madigan Army Medical CenterLead Sponsor
48 Previous Clinical Trials
18,116 Total Patients Enrolled
Bruce PierPrincipal InvestigatorMadigan Chief of REI, Department of OBGYN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been admitted to this experiment?

"Unfortunately, this trial is no longer open for registration. It was initially posted on January 31st 2022 and last edited a little over 10 days later on February 11th. If you are hunting for other clinical trials, the current selection includes 246 studies recruiting patients with infertility issues in females as well as 79 medical experiments that accept participants taking Ketorolac 30mg orally."

Answered by AI

What medicinal applications is Ketorolac 30mg oral most effective in treating?

"Ketorolac 30mg oral is a commonly prescribed medication to treat pupil. Additionally, this pharmaceutical has also been known to abate ailments such as catarrh, miosis disorder, and muscle spasms."

Answered by AI

Could you provide insights into the previous research related to Ketorolac 30mg oral?

"Currently, 79 clinical trials are probing Ketorolac 30mg oral with 18 of them at the Phase 3 stage. Most of these studies take place in Los Angeles yet there 146 other locations conducting related research."

Answered by AI

What hazards might occur with a 30mg oral dose of Ketorolac?

"There is sufficient clinical evidence from Phase 4 trials to support the safety and efficacy of Ketorolac 30mg oral, thus it receives a score of 3."

Answered by AI

Does this trial encompass geriatric participants?

"This clinical trial is seeking individuals aged 18 to 45; however, there are other studies recruiting minors and seniors respectively (41 trials for those under 18 & 81 trials for participants over age 65)."

Answered by AI

Is this research project open to new participants?

"Evidently, the clinical trial hosted on clinicaltrials.gov is no longer actively recruiting patients; however it was initially posted on January 31st 2022 and last updated 11 days ago. Despite this particular study's conclusion of recruitment activities, there are 325 other trials that remain open to enrolment at present."

Answered by AI

What criteria makes a candidate an optimal participant for this experiment?

"This research is looking for 88 premenopausal women, aged 18-45, who have been diagnosed with sterility. The requirements to enroll in this trial are a diagnosis of infertility and being an adult female within the specified age range."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
Madigan Army Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
~28 spots leftby Apr 2025